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Rep78 is the major regulatory protein of adenoassociated virus (AAV). Rep78 is able to transcriptionally regulate all three
of AAV’s promoters, as well as a variety of heterologous promoters. In an attempt to understand the mechanism of action
by which Rep78 is able to regulate gene expression, we are investigating Rep78’s possible protein–protein interaction with
basal transcription factors. One such critical basal transcription factor is the human TATA binding protein, TBP. TBP is a core
factor required for the assemblage of the transcription initiation complex, TFIID. In this report an in vitro interaction between
Rep78 and TBP was demonstrated in three different assay systems, including West(far)–Western analysis, electrophoretic
mobility shift assay–supershift, and coimmunoprecipitation. Furthermore, using the yeast GAL4 two-hybrid system, an in vivo
interaction between Rep78 and TBP was also demonstrated. Further still, the amino half of Rep78 is shown to be needed for
Rep78–TBP interaction. Mutations within this region of Rep78 are known to be defective for transcriptional regulatory ability,
suggesting a biological role for this interaction. Thus, Rep78 may regulate transcription through binding and regulating TBP’s
numerous interactions. Furthermore, as Rep78 is known to bind at least one other transcription factor (Sp1) and likely others,
Rep78 may function as a TBP-associated factor in an altered TFIID-like complex. © 1998 Academic Press
INTRODUCTION
Adeno-associated virus (AAV)2 is a helper-dependent
human parvovirus which requires co-infection of the cell
by adenovirus or herpes simplex virus to allow for AAV
productive infection (Buller et al., 1981; Hoggan et al.,
1966). AAV is an interesting virus for study due to its
unique life cycle, its negative association with cervical
cancer (Georg-Fries et al., 1984; Mayor et al., 1976), and
its use as a gene therapy vector (Hermonat and Muzyc-
zka, 1984; Tratschin et al., 1985; LaFace et al., 1988;
Hermonat et al., 1997a). Another reason for interest in
AAV is its encoded, multifunctional protein, Rep78. One
of four rep proteins (Mendelson et al., 1986), Rep78 is
needed for AAV DNA replication (Hermonat et al., 1984;
Tratschin et al., 1984), for human chromosome 19-spe-
cific integration of AAV DNA (Weitzman et al., 1994), and
possibly for the packaging of AAV DNA into virions
(Wistuba et al., 1995; Prasad and Trempe, 1995).
Also very important for AAV’s life cycle is Rep78’s role
as the major regulatory protein of AAV gene expression.
Rep78 is able to both transactivate and transrepress AAV
promoters (Labow et al., 1986; Beaton et al., 1989; Kyostio
et al., 1994; Horer et al., 1995; McCarty et al., 1994),
possibly by physically binding to AAV promoter se-
quences (McCarty et al., 1994). Rep78 is also able to
regulate (Labow et al., 1988; Hermonat, 1991; Antoni et
al., 1991; Hermonat, 1994a,b; Oelze et al., 1994; Rittner et
al., 1992) and bind to (Batchu et al., 1994, 1995; Wonder-
ling and Owens, 1996) a variety of heterologous promot-
ers as well. Likely coupled with AAV’s (Rep78’s) ability to
regulate transcription is its anti-oncogenic properties,
which have been been observed in a variety of different
systems (Kirchstein et al., 1968; Mayor et al., 1973; Os-
trove et al., 1981; Hermonat, 1989, 1991, 1994a,b, 1997b;
Khleif et al., 1991; Su and Wu, 1996). Finally, Rep78 has
recently been found to recognize and bind proteins, in-
cluding itself (Weitzman et al., 1996; Hermonat and
Batchu, 1997c; Smith et al., 1997) and AAV’s capsid pro-
teins (Prasad and Trempe, 1995; Wistuba et al., 1995;
Hermonat et al., 1997c). Most recently, Rep78 has been
shown to bind and to act through the cellular transcrip-
tion factor Sp1 (Hermonat et al., 1996; Pereira and Muzy-
czka, 1997) and to bind a variety of as yet uncharacter-
ized cellular proteins (Hermonat et al., 1997d).
Understanding the mechanism by which Rep78 is able
to transcriptionally regulate homologous and heterolo-
gous promoters is important for understanding AAV bi-
ology, for understanding AAV’s anti-cancer abilities, and
for AAV’s use as a gene therapy vector. The general
mechanisms of transcription initiation by cellular and
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viral transcription factors continues to be revealed. Pos-
sibly the most central protein in the transcription initia-
tion process is the TATA box binding protein, TBP. TBP is
essential for the transcription by all three RNA poly-
merases, which is complexed into SL1 (Comai et al.,
1992), TFIID (Gill and Tjian, 1992; Pugh and Tjian, 1992),
and TFIIB (White and Jackson, 1992) for its function in the
RNA polymerase I, II, and III systems, respectively. If
Rep78 is able to bind TBP, this interaction directly implys
new hypotheses for specific mechanisms of action for
Rep78 transcriptional regulation. In fact, all well-studied
eukaryotic DNA viruses encode proteins that modulate
DNA transcription, and in almost all cases the viral fac-
tors exert their influence by targeting specific cellular
transcription factors (Geisberg et al., 1994; Goodrich et
al., 1993; Gruda et al., 1993). Here we demonstrate, by
four different assay systems, that Rep78 binds TBP in
vitro and in vivo. Furthermore, the amino half of Rep78 is
found to be required for its interaction with TBP. The
central importance of TBP in gene regulation suggests
the possibility that the Rep78–TBP interaction may be
very important. This conclusion is also supported by the
finding that the region of Rep78 required for binding TBP
is also required for Rep78 transcriptional regulatory ac-
tivity (Labow et al., 1986; Tratschin et al., 1986; Hermonat,
1989, 1991; Yang et al., 1992; Horer et al., 1995).
RESULTS
Rep78 binds TBP in vitro as determined by
West–Western analysis
Many transcriptional regulators have been demon-
strated to interact with components of basal transcrip-
tional machinery. We hypothesized that Rep78 might bind
to the TATA binding protein (TBP). Rep78–TBP interaction
was first investigated in vitro by West–Western analysis.
Affinity-purified TBP was SDS–PAGE separated and elec-
troblotted onto nitrocellulose papers, and the nonspecific
binding sites on the blots were blocked by incubating
them with 1% BSA blocking solution. Then these blots
containing TBP were probed with 35S-labeled maltose
binding protein [35S]MBP or [35S]MBP–Rep78 protein so-
lution, washed, and autoradiographed (Figs. 1A and 1B).
A specific band at the position of TBP appeared when
probed with [35S]MBP–Rep78 (Fig. 1A). An identical blot
probed with [35S]MBP (Fig. 1B) showed no binding to
TBP. This finding is consistent with our other studies, in
which MBP (without the Rep78 moity) is not found to
readily bind other proteins under these conditions (Her-
monat et al., 1996, 1997d). Also included on the nitrocel-
lulose filters were the MBP–Rep78 (known to bind
Rep78; Hermonat et al., 1997c) and MBP proteins, which
served as the positive and negative controls for Rep78
binding, respectively. Another set of blots, one shown
probed with MBP–Rep78 in Fig. 1C, were analyzed using
chemiluminescence as the signal. In these assays the
blots were first incubated with either unlabeled MBP–
Rep78 or MBP. Later the blots were probed with anti-
MBP antibodies and the bands were visualized with
luminol as mentioned under Materials and Methods. As
with the blots of Figs. 1A and 1B the TBP band appears
only when the blots were incubated with MBP–Rep78
probe (Fig. 1C) and not when incubated with MBP
probe (negative chemiluminescence assay for MBP not
shown).
Rep78 binds TBP in vitro as determined by EMSA
supershift and coimmunoprecipitation analyses
To support the West–Western finding showing Rep78–
TBP interaction, EMSA–supershift analysis was used.
Rep78 can selectively interact with AAV terminal repeat
(TR) DNA. This Rep78–TR complex can be easily ob-
served in an EMSA assay. To this complex we added
TBP to observe if a new, larger TR–Rep78–TBP complex
could be observed as a higher band (supershift). As
shown in Fig. 2, in the presence of TBP the already
shifted low-mobility band, the TR–Rep78 complex, was
further supershifted, indicating the interaction of the
Rep78–AAV TR DNA complex with TBP. It should also be
noted that no TR–Rep78 band remained. All of this com-
plex was supershifted. This suggested to us that the
affinity of TBP for the TR–Rep78 complex may be quite
high. Specificity of Rep78s interaction with TBP was
confirmed by the inability of TBP to bind TR DNA directly.
This small TBP-induced supershift has been seen by
others for TBP 1 p53 2 DNA interaction (Deb et al., 1994)
(TBP is small, 37 kDa).
FIG. 1. Rep78 recognizes TBP in vitro by West(far)–Western analysis.
(A) West–Western analysis demonstrating Rep78–Sp1 interaction using
35S-labeled MBP–Rep78 probe. 100 ng of MBP, MBP–Rep78, and TBP
each was SDS–PAGE separated, electroblotted onto nitrocellulose, and
probed with 35S-labeled MBP–Rep78. Note that a band is clearly visible
in the TBP lane, suggesting significant Rep78–TBP recognition. (B)
West–Western analysis, equivalent to A except that the blot was probed
with 35S-labeled MBP. Note that no binding is seen. (C) West–Western
analysis, similar to A, demonstrating Rep78–TBP interaction using
polyclonal anti-Rep78 antibodies and chemiluminescence as de-
scribed under Materials and Methods. Note that, again, Rep78 is found
binding to TBP.
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Coimmunoprecipitation was a third in vitro assay sys-
tem used to investigate Rep78–TBP binding. Equal ali-
quots of [35S]TBP were incubated with MBP–Rep78 or
MBP and then any complexes formed were immunopre-
cipitated with anti-MBP antibodies and Staph A. As
shown in Fig. 3, MBP–Rep78 was able to complex with
TBP. In contrast, MBP had little affinity. Thus, three in vitro
assays demonstrate Rep78–TBP interaction.
Rep78 binds TBP in vivo as determined in the yeast
GAL4 two-hybrid system
To extend the investigation of Rep78–TBP interaction
in vivo, the yeast GAL4 two-hybrid system was utilized
(Chein et al., 1991). Two-hybrid cDNAs were constructed
as described under Materials and Methods. Briefly, the
Rep78 open reading frame (ORF) was fused in frame with
the GAL4 DNA binding domain (BD) ORF and the TBP
ORF was fused in frame with the transactivation domain
(AD) ORF. The AD and BD containing yeast plasmids
each contained a different selectable marker gene.
These constructs were transfected and selected for in
yeast, both alone and together. In this assay system the
level of b-galactosidase activity from a GAL4-dependent
reporter construct present in the yeast usually correlates
with the strength of the in vivo interaction between the
two proteins being examined (e.g., Large T with p53, Fig.
4). The activity of an endogenous GAL4-responsive re-
porter promoter driving the LacZ gene was then mea-
sured in yeast extracts from cells carrying the indicated
plasmids, and the data are shown in Fig. 4. These data
represent the results, as units of b-galactosidase activ-
ity/mg protein, from three different yeast clones from
each of the indicated transfections. The yeast containing
only BD–Rep78 or AD–TBP gave expression levels in the
range similar to other negative controls, AD–SV40 (large
T) and BD–plasminC 1 AD-SV40 (2.58 6 0.11, 2.61 6 0.21,
2.22, 2.13 6 1.05 units/mg protein, respectively). It should
be noted that the LacZ indicator gene within the yeast, in
fact, contains a TATA box. When initially designing these
experiments there was concern that the AD–TBP chi-
meric protein might be able to significantly transactivate
the reporter promoter without the need of a second BD
containing chimeric cDNA. Fortunately, AD–TBP does not
have this ability. As expected, the positive control, BD–
p53 1 AD–SV40, was significantly elevated over all of
these negative controls (7.73 6 2.39). Most importantly,
the experimental situation, BD–Rep78 1 AD–TBP, gave a
significant level of expression (4.51 6 0.97 units/mg)
above all the negative controls, but not as high as the
p53–SV40 large T interaction. Thus, these data demon-
strate a measurable in vivo interaction between Rep78
and TBP and support the validity of the in vitro studies.
The amino half of Rep78 is required for Rep78–TBP
interaction
To observe which general part of the Rep78 protein
was required for its recognition of the TBP protein two
Rep78 mutants, Bam-Rep and Eco-Rep, were used to
map the effect (Hermonat et al., 1996). Bam-Rep deletes
FIG. 3. Rep78 recognizes TBP by coimmunoprecipitation analysis of
[35S]TBP with MBP–Rep78 and anti-MBP antibodies. [35S]TBP protein
was generated by in vitro transcription/translation. Equal aliquots were
incubated with MBP–Rep78 protein and anti-MBP antibodies and pro-
tein A as indicated, centrifuged, washed three times, and analyzed by
SDS–PAGE. An equal aliquot of [35S]TBP protein was also run as a
marker. Note that [35S]TBP is coimmunoprecipitated with MBP–Rep78,
while MBP was not effective in this.
FIG. 2. Rep78 recognizes TBP, while Rep78 is bound to its DNA
substrate (EMSA–supershift analysis). The AAV TR, the natural sub-
strate for Rep78–DNA binding, was 32P-radiolabled, incubated with the
indicated proteins, and analyzed by PAGE. Note that a band forms
when MBP–Rep78 and the TR are incubated together. In contrast, TBP
and MBP were unable to generate a complex with the TR. Finally, note
that the addition of TBP to MBP–Rep78 plus TR DNA resulted in a
slightly higher shifted band, a supershift. Although the difference with
and without TBP is small, this difference is due to TBP’s small molec-
ular weight, 37 kDa. This small EMSA supershift has been seen by
others in studies of p53–TBP interaction (Deb et al., 1994).
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the 59 243-amino-acid sequences from the Rep78 part of
MBP–Rep78, while Eco-Rep deletes to amino acid 555.
Shown in Fig. 5, Bam-Rep was unable to bind TBP (ex-
periments 2 and 4) as determined by nondenaturing
PAGE or SDS–PAGE and West–Western analysis (horse-
radish peroxidase (HRPO) enzymatic assay, see Materi-
als and Methods), when compared to MBP–Rep78 (ex-
periments 1 and 3). Eco-Rep was also defective for this
activity (data not shown). These data indicate that the 59
amino half of Rep78 is required for Rep78–TBP interac-
tion. This region is required for both transcriptional trans-
activation and transrepression activity (Labow et al.,
1986; Tratschin et al., 1986; Hermonat, 1989, 1991; Yang
et al., 1992; Horer et al., 1995), suggesting a biological
role for this interaction.
DISCUSSION
This report demonstrates the interaction between the
adeno-associated virus-encoded Rep78 and human TBP
proteins by one in vivo and three in vitro assays. Further-
more, it is demonstrated that the amino-terminal half of
Rep78 is required for interaction with TBP. As this same
region is required for both transactivation and transre-
pression of various promoters by Rep78, these data
suggest a biological role for Rep78–TBP interation
(Labow et al., 1986; Tratschin et al., 1986; Hermonat,
1989, 1991; Yang et al., 1992; Horer et al., 1995). TBP is a
critcal factor in transcription initiation. In TATA box con-
taining promoters the binding of this motif by TBP, along
with the assemblage of a variety of TBP accessory pro-
teins (TAFs, TBP-associated proteins), forms the initiation
complex called TFIID (Verrijer and Tjian, 1996; Roeder,
1996). These TAFs then interact with more distant tran-
scription factors which bind to enhancer elements and
with RNA polymerase II, plus its accessory proteins, to
initiate transcription.
The finding of an interaction between Rep78 and TBP
FIG. 5. The amino-terminal half of Rep78 is required for Rep78–TBP
interaction, as demonstrated by West–Western analysis. The amino-
half-deleted mutant of MBP–Rep78, Bam-Rep, cannot interact with TBP,
while it is still able to interact with Rep78. 100 ng each of MBP–Rep78
and TBP proteins was PAGE or SDS–PAGE separated as indicated and
electroblotted onto nitrocellulose, and an HRPO enzymatic assay was
performed after probing with cold MBP–Rep78 and anti-MBP antibod-
ies, as mentioned under Materials and Methods. Blots 1 and 3 were
probed with cold MBP–Rep78; 2 and 4 were probed with cold Bam-Rep.
Note that under both native (PAGE) and denatured (SDS–PAGE) condi-
tions, MBP–Rep78 recognizes both itself and TBP. In contrast, Bam-Rep
recognizes only MBP–Rep78.
FIG. 4. Rep78 binds TBP in vivo as determined by analysis in the
yeast GAL4 two-hybrid system. Two chimeric GAL4-based cDNAs,
pBD–Rep78 and pAD–TBP, were constructed for expression in yeast as
described under Material and Methods. The two plasmids were then
introduced alone and together by transfection and selection in yeast.
Various control yeast cDNAs were also introduced into yeast. The level
of b-galactosidase activity of three yeast clones from each of the
indicated transfections was then determined as described under Ma-
terials and Methods using the X-gal substrate and quantified by spec-
troscopic analysis at 420 nm. Note that all of the negative controls, the
four middle bars, resulted in a relatively low signal. In contrast, both the
positive control [BD–SV40 (Large T) 1 AD–p53] and the experimental
BD–Rep78 1 AD–TBP gave significantly higher signals. Thus, these
latter data are consistent with significant Rep78–TBP interaction in
yeast in vivo. The activities of the yeast extracts were as follows, in
units/mg protein: positive control, BD–SV40 1 AD–p53 was 7.73 6 2.39.
Negative controls, BD–SV40 1 AD–pLaminC was 2.13 6 1.05; BD–SV40
was 2.22 (n 5 1); BD–Rep78 was 2.58 6 0.11; and AD–TBP was 2.61 6
0.21. The experimental, BD–Rep78 1 AD–TBP was 4.51 6 0.97.
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provides a new and important insight into Rep78’s pos-
sible mechanism(s) for regulating gene expression. Mul-
tiple mechanisms are possible. For example Rep78 bind-
ing to TBP might have significant effects on at least some
of the TBP–TAF interactions. Rep78 might prevent certain
TAFs from entering the TFIID complex and, thus, alter the
activity of this complex. Such a mechanism has been
suggested for p53 inhibition of transcription by direct
binding of TBP (Seto et al., 1992). Furthermore, we find
Rep78 binding to a other transcriptionally relevant pro-
teins such as Sp1 (Hermonat et al., 1996). Therefore, a
second way to look at this same hypothesis is that Rep78
might, itself, serve as a ‘‘TAF,’’ possibly replacing some of
TAF–p250 functions serving as a ‘‘connector’’ or ‘‘modu-
lator.’’ Effector proteins which normally do not act
through TBP might then be able to in the presence of
Rep78. There is precedence for viral proteins serving this
function. For example, SV40 Large T is able to bind TBP
and replace TAF–p250 function to a significant extent
(Damania and Alwine, 1996; Martin et al., 1993). In any
case, our data indicate that there is an in vivo TBP–
Rep78 complex.
The strength of TBP’s affinity to the Rep78–TR DNA
complex, as indicated by the complete supershift of the
Rep78–TR complex by TBP in Fig. 2, suggests to us
another possibility as to how Rep78 may regulate gene
expression. Rep78 is known to bind DNA substrates
which contain multimers of the sequence GAGC (Chiorini
et al., 1995). For example, the AAV TR contains a triplex
concatemer of this sequence at the major binding site
within the TR (Im and Muzyczka, 1990). The ability of the
Rep78–DNA complex to attract TBP stimulates a second
hypothesis: Rep78, bound to its DNA motif, might serve
as a functional equivalent to the TATA box for attracting
TBP and initiating transcription. In fact, a Rep78 binding
site is known to reside adjacent to the TATA box in the
AAV p5 promoter (McCarty et al., 1994). In any case, the
multiple possible consequences of the Rep78–TBP inter-
action likely open a new chapter on Rep78 activity and
function. Rep78 has already proved to be one of the most
(if not the most) multifunctional proteins known. This
study, along with the likely new functions implied by this
study, suggests that we are far from finished in writing a
complete summary chapter on this important protein.
MATERIALS AND METHODS
MBP and MBP–Rep78 protein production and
purification
Purified TBP was obtained from Promega. TBP, labeled
with 35S, was generated by in vitro transcription/transla-
tion by using the plasmid pTb-TBP (obtained from Robert
Tjian) (Peterson et al., 1990) and the Amersham Life
Science ‘‘Linked T7 transcription–translation system’’ as
directed by the kit instructions. Rep78 protein was pro-
duced as a fusion protein with MBP using the New
England Biolabs Protein Fusion and Purification Kit ac-
cording to manufacturer’s instructions. A detailed proto-
col for the construction is given elsewhere (Batchu et al.,
1995). For the preparation of 35S-labeled MBP and MBP–
Rep78 chimeric protein, essentially the same protocol is
used with minor modifications. Briefly, overnight cultures
of pMAL–Rep78 containing bacteria were inoculated into
10 ml rich medium and grown until the absorbancy
reached A600 0.5. The bacteria were centrifuged and
resuspended in minimal medium previously heated to
37°C. After approximately 10 min growth in minimal me-
dium, 100 mCi of [35S]methionine, 50 ml of 2 mM methi-
onine-free amino acid mix, and IPTG were added to a
final concentration of 0.3 mM. Incubation was continued
for 30 min more in shakers at 37°C, and unlabeled
methionine added to a final concentration of 1 mM, and
2 ml of Luria broth was added. Cells were spun down,
suspended in column buffer (25 mM Tris, pH 7.5, 200 mM
NaCl, 1 mM DTT, and 1 mM EDTA) and stored at 270°C
for 30 min. Purification of induced chimeric protein in
labeled media was then carried out as for purifying
unlabeled MBP–Rep78 (Batchu et al., 1995).
West–Western analyses
SDS–polyacrylamide gel electrophoretically (PAGE)-
separated proteins were electroblotted onto nitrocellu-
lose as described by Towbin et al. (1979). The blots were
probed using two different detection techniques: 35S-
labeled protein probing or antibody/chemiluminescence
probing. After electroblotting additional protein binding
sites on the nitrocellulose were blocked by incubation for
30 min at room temperature in 1% protease-free bovine
serum albumin prepared in binding buffer (25 mM Tris,
pH 7.8, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1 mM
EDTA, 5 mM KCl). After the BSA blocking step, filters
were either incubated in 35S-labeled MBP or MBP–
Rep78 for 30 min, prepared in 0.1% protease-free BSA in
blotting buffer, with agitation. The filters were then sub-
jected to three washings in blotting buffer for 10 min
each with constant agitation. The blots were then dried
and autoradiographed. For chemiluminescence assays,
protein blots were incubated with unlabeled MBP–Rep78
(10 mg/ml) after a BSA blocking step. The blots were then
probed by incubation with a 1:200 dilution of polyclonal
anti-Rep rabbit antibodies (provided by James Trempe)
for 30 min at room temperature with constant agitation.
The blots were then subjected to three washings for 10
min each with constant agitation. The blots were incu-
bated with a 1:10,000 dilution of anti-rabbit antibodies
conjugated to HRPO for 30 min at room temperature with
agitation. After extensive washing (33), blots were incu-
bated in peroxidase enzymatic assay solution consisting
of 5 mg of 4-chloronaphthol substrate and 10 ml of H2O2.
After the appearance of the bands the blot was thor-
oughly rinsed with water and dried. For chemilumi-
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nescene probing, the blots were incubated in luminol
solution (Amersham ECL system) for 1 min and autora-
diographed for 1 min.
Electrophoretic mobility shift–supershift
(EMSA–supershift) analysis
The AAV TR DNA was used as the labeled target for
Rep78 binding, and to these two components cold TBP
was added to observe a supershift. The AAV TR DNA
substrate, generated by the ligation of three synthetic
oligonucleotides (Batchu et al., 1995), was end labeled
with [32P]ATP using polynucleotide kinase and reprecipi-
tated and dissolved in TE buffer. Approximately 0.1 ng of
TR (2000 cpm) was incubated with 100 ng of affinity-
purified chimeric Rep78 protein in the binding buffer (25
mM HEPES, pH 7.5, 1 mg/ml BSA, 1 mg/ml poly(dI-dC), 5
mM MgCl2, 1 mMDTT) for 15 min at room temperature.
Approximately 100 ng of affinity-purified TBP (Promega)
was added where indicated and incubated for 10 min
more. The mixture was then applied onto a 4% acryl-
amide gel made in 0.5% TBE and electrophresis was
conducted for 3 h. Gels were dried and autoradio-
graphed.
Coimmunoprecipitation analysis
[35S]TBP protein was generated by in vitro transcrip-
tion/translation by using the plasmid phTBP (obtained
from Robert Tjian) and the Amersham Life Science
‘‘Linked T7 transcription–translation system’’ as directed
by the kit instructions. Equal aliquots (2000 CPM) of
[35S]TBP protein were used for the coimmunoprecipita-
tion assays. Initially, anti-MBP antibodies (New England
Biolabs, 100 ml) were incubated with protein A–Sepha-
rose (Bio-Rad, 500 ml) in 500 ml of binding buffer. The
complex was then washed three times with binding
buffer. The resulting complex was then incubated with
MBP or MBP–Rep78 (amount as indicated), followed by
incubation with [35S]TBP. Incubations were carried out at
room temperature for 30 min and after each incubation
the complexes were washed three times with 1 ml of
binding buffer. The final products were boiled in SDS–
PAGE (Laemmli) buffer and analyzed by 8% SDS–PAGE,
staining, and autoradiography.
Yeast GAL4 two-hybrid cDNA analysis
Basic reagents and protocols for this assay were ob-
tained from the HybriZAP Two-hybrid cDNA Gigapack
Cloning Kit (Stratagene). The plasmid pBD-Rep78 was
constructed by ligating the 1.9-kb SphI–XhoI fragment
from pMAL–Rep78, containing the full-length ORF of
Rep78, into an altered GAL4-DB plasmid. The altered
vector contained a new polylinker allowing the Rep78
ORF to be ligated, or fused, in frame with the GAL4 BD
ORF. The plasmid pAD–TBP was constructed by ligating
the 1 kb of NdeI fragment from pTb–TBP, containing a full
ORF of human TBP, into an altered pAD-GAL4 vector. The
altered pAD-GAL4 contained a new polylinker allowing
the TBP ORF to be ligated in frame with the GAL4 AD
ORF. Additional plasmids pGAL4, GAL4-BD-p53 (referred
to here as pBD-p53), GAL4-BD-pLamin C (referred to
here as pBD-pLaminC), and GAL4-AD-SV40 (referred to
as pAD-SV40) were provided by the kit. Yeast strains
YRG-2 were grown in YPD medium. Transformation of the
yeast with the plasmid DNAs was carried out using the
lithium acetate method, and transformed yeast clones
were selected in the appropriate synthetic medium lack-
ing uracil, tryptophan, or leucine as described in the kit.
After transfection and selection of the yeast the b-galac-
tosidase activity was quantitated. Yeast clones, grown to
mid log phase (A600 . 1.0), were collected by low-speed
centrifugation. The yeast cells were resuspended in 1 ml
of Z-buffer (60 mM Na2HPO4, 40 mM NaH2 PO4, 10 mM
KCl, 1 mM MgSO4, 50 mM b-mercaptoethanol, pH 7.0)
and placed on ice. The cells in the 1-ml reaction mixture
were permeabilized with one drop of 0.1% SDS and two
drops of chloroform. Then, the reaction were started with
the addition of 0.2 ml of 4 mg/mI o-nitrophenyl-b-D-gal-
actoside at 30°C and stopped by adding 0.5 ml of 1 M
NaCO3. b-Galactasidase activity was determined spec-
trophotometrically by absorbance at 420 nm and A550
using the equation U 5 (1000 3 1(A420) 2 (1.75 3
A550))/(t 3 v 3 A600) [(t 5 time of the reaction (min); v 5
volume of yeast culture used in the reaction mixture (ml)].
The value of b-galactasidase units activity/mg protein is
an average value of three independent yeast colonies
from each of the indicated transfections.
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